VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: Involvement of the VLDL receptor

Journal of Lipid Research

Volumn 40, Issue 5, 1999, Pages 913-919

  Nilsson, Lennart ^a   Gåfvels, Mats ^a   Musakka, Leena ^a   Ensler, Katharina ^a   Strickland, Dudley K ^b   Angelin, Bo ^a   Hamsten, Anders ^a   Eriksson, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HOLLAND LABORATORY   (United States)

Author keywords

Atherosclerosis; Transfection; VLDL response element

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION;

EID: 0345711546     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Austin, M. A. 1991. Plasma triglyceride and coronary heart disease. Arterioscler. Thromb. 11: 2-14.
2. Juhan-Vague, I., M. C. Alessi, and P. Vague. 1991. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia. 34: 457-462.
3. Hamsten, A., and P. Eriksson. 1994. Fibrinolysis and atherosclerosis: an update. Fibrinolysis. 8: 253-262.
4. Stiko-Rahm, A., B. Wiman, A. Hamsten, and J. Nilsson. 1990. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 10: 1067-1073.
5. Mussoni, L., L. Mannucci, M. Sirtori, M. Camera, P. Maderna, L. Sironi, and E. Tremoli. 1992. Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler. Thromb. 12: 19-27.
6. Kaneko, T., H. Wada, Y. Wakita, K. Minamikawa, T. Nakase, Y. Mori, K. Deguchi, and S. Shirakawa. 1994. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins. Blood Coagul. Fibrinolysis. 5: 385-392.
7. Sironi, L., L. Mussoni, L. Prati, D. Baldassarre, M. Camera, C. Banfi, and E. Tremoli. 1996. Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL. Arterioscler. Thromb. Vasc. Biol. 16: 89-96.
8. Eriksson, P., L. Nilsson, F. Karpe, and A. Hamsten. 1998. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 18: 20-26.
9. Nilsson, L., C. Banfi, U. Diczfalusy, E. Tremoli, A. Hamsten, and P. Eriksson. 1998. Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18: 1679-1685.
10. Yamamoto, T., C. G. Davis, M. S. Brown, W. J. Schneider, M. L. Casey, J. L. Goldstein, and D. W. Russell. 1984. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 39: 27-38.
11. Barber, D. L., E. J. Sanders, R. Aebersold, and W. J. Schneider. 1991. The receptor for yolk lipoprotein deposition in the chicken oocyte. J. Biol. Chem. 266: 18761-18770.
12. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1992. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89: 9252-9256.
13. Herz, J., U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, and K. K. Stanley. 1988. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7: 4119-4127.
14. Strickland, D. K., J. D. Ashcom, S. Williams, W. H. Burgess, M. Migliorini, and W. S. Argraves. 1990. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265: 17401-17404.
15. Raychowdhury, R., J. L. Niles, R. T. McCluskey, and J. A. Smith. 1989. Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science. 244: 1163-1165.
16. Korenberg, J. R., K. M. Argraves, X. N. Chen, H. Tran, D. K. Strickland, and W. S. Argraves. 1994. Chromosomal localization of human genes for the LDL receptor family member glycoprotein 330 (LRP2) and its associated protein RAP (LRPAP1). Genomics. 22: 88-93.
17. Battey, F. D., M. E. Gåfvels, D. J. FitzGerald, W. S. Argraves, D. A. Chappell, J. F. Strauss III, and D. K. Strickland. 1994. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269: 23268-23273.
18. Takahashi, S., J. Suzuki, M. Kohno, K. Oida, T. Tamai, S. Miyabo, T. Yamamoto, and T. Nakai. 1995. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270: 15747-15754.
19. Kobayashi, K., K. Oka, T. Forte, B. Ishida, B. Teng, K. Ishimura-Oka, M. Nakamuta, and L. Chan. 1996. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J. Biol. Chem. 271: 6852-6860.
20. Kozarsky, K. F., K. Jooss, M. Donahee, J. F. Strauss III, and J. M. Wilson. 1996. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene [published erratum appears in Nat. Genet. 1996. Jul;13(3):374]. Nature Genet. 13: 54-62.
21. Argraves, K. M., K. F. Kozarsky, J. T. Fallon, P. C. Harpel, and D. K. Strickland. 1997. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 100: 2170-2181.
22. Medh, J. D., G. L. Fry, S. L. Bowen, M. W. Pladet, D. K. Strickland, and D. A. Chappell. 1995. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270: 536-540.
23. Gåfvels, M. E., M. Caird, D. Britt, C. L. Jackson, D. Patterson, and J. F. Strauss III. 1993. Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. Somat. Cell Mol. Genet. 19: 557-569.
24. Webb, J. C., D. D. Patel, M. D. Jones, B. L. Knight, and A. K. Soutar. 1994. Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. Hum. Mol. Genet. 3: 531-537.
25. Masuzaki, H., H. Jingami, T. Yamamoto, and K. Nakao. 1994. Effects of estradiol on very low density lipoprotein receptor mRNA levels in rabbit heart. FEBS Lett. 347: 211-214.
26. Jokinen, E. V., K. T. Landschulz, K. L. Wyne, Y. K. Ho, P. K. Frykman, and H. H. Hobbs. 1994. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J. Biol. Chem. 269: 26411-26418.
27. Argraves, K. M., F. D. Battey, C. D. MacCalman, K. R. McCrae, M. Gåfvels, K. F. Kozarsky, D. A. Chappell, J. F. Strauss III, and D. K. Strickland. 1995. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J. Biol. Chem. 270: 26550-26557.
28. Multhaupt, H. A., M. E. Gafvels, K. Kariko, H. Jin, C. Arenas-Elliot, B. I. Goldman, J. F. Strauss III, B. Angelin, M. J. Warhol, and K. R. McCrae. 1996. Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am. J. Pathol. 148: 1985-1997.
29. Wyne, K. L., K. Pathak, M. C. Seabra, and H. H. Hobbs. 1996. Expression of the VLDL receptor in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 16: 407-415.
30. Nakazato, K., T. Ishibashi, J. Shindo, M. Shiomi, and Y. Maruyama. 1996. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am. J. Pathol. 149: 1831-1838.
31. Desai, K. S., A. I. Gotlieb, and G. Steiner. 1985. Very low density lipoprotein binding to cultured aortic endothelium. Can. J. Physiol. Pharmacol. 63: 809-815.
32. Niemeier, A., M. Gåfvels, J. Heeren, N. Meyer, B. Angelin, and U. Beisiegel. 1996. VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J. Lipid Res. 37: 1733-1742.
33. Rojas, C., S. Enerback, and G. Bengtsson-Olivecrona. 1990. Synthesis and secretion of active lipoprotein lipase in Chinese-hamster ovary (CHO) cells. Biochem. J. 271: 11-15.
34. Rudling, M. 1992. Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J. Lipid Res. 33: 493-501.
35. McFarlane, A. S. 1958. Efficient trace labeling of proteins with iodine. Nature. 182: 53-57.
36. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
37. Karpe, F., G. Steiner, T. Olivecrona, L. A. Carlson, and A. Hamsten. 1993. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 91: 748-758.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: a Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Alksnis, M., T. Barkhem, P. E. Stromstedt, H. Ahola, E. Kutoh, J. A. Gustafsson, L. Poellinger, and S. Nilsson. 1991. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J. Biol. Chem. 266: 10078-10085.
40. Kalb, V. F., Jr., and R. W. Bernlohr. 1977. A new spectrophotometric assay for protein in cell extracts. Anal. Biochem. 82: 362-371.
41. Vlodavsky, I., P. E. Fielding, C. J. Fielding, and D. Gospodarowicz. 1978. Role of contact inhibition in the regulation of receptor-mediated uptake of low density lipoprotein in cultured vascular endothelial cells. Proc. Natl. Acad. Sci. USA. 75: 356-360.
42. van Hinsbergh, V., L. Havekes, J. Emeis, E. van Corven, and M. Scheffer. 1983. Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis. 3: 547-559.
43. Rudling, M., G. Norstedt, H. Olivecrona, E. Reihner, J. A. Gustafsson, and B. Angelin. 1992. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA. 89: 6983-6987.
44. Sakai, J., A. Hoshino, S. Takahashi, Y. Miura, H. Ishii, H. Suzuki, Y. Kawarabayasi, and T. Yamamoto. 1994. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269: 2173-2182.
45. Beisiegel, U., W. J. Schneider, M. S. Brown, and J. L. Goldstein. 1982. Immunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia. J. Biol. Chem. 257: 13150-13156.
46. Herz, J., J. L. Goldstein, D. K. Strickland, Y. K. Ho, and M. S. Brown. 1991. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 266: 21232-21238.
47. Willnow, T. E., J. L. Goldstein, K. Orth, M. S. Brown, and J. Herz. 1992. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267: 26172-26180.
48. Sege, R. D., K. Kozarsky, D. L. Nelson, and M. Krieger. 1984. Expression and regulation of human low-density lipoprotein receptors in Chinese hamster ovary cells. Nature. 307: 742-745.
49. Patel, D. D., R. A. Forder, A. K. Soutar, and B. L. Knight. 1997. Synthesis and properties of the very-low-density-lipoprotein receptor and a comparison with the low-density-lipoprotein receptor. Biochem. J. 324: 371-377.
50. Hiltunen, T. P., J. S. Luoma, T. Nikkari, and S. Yla-Herttuala. 1998. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation. 97: 1079-1086.
51. Hamsten, A., B. Wiman, U. de Faire, and M. Blomback. 1985. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313: 1557-1563.
52. Avellone, G., V. Di Garbo, R. Cordova, A. V. Panno, G. Ranelli, R. de Simone, and G. D. Bompiani. 1993. Fibrinolytic effect of gemfibrozil versus placebo administration in response to venous occlusion. Fibrinolysis. 7: 416-421.
53. Andersen, P., P. Smith, I. Seljeflot, S. Brataker, and H. Arnesen. 1990. Effects of gemfibrozil on lipids and haemostasis after myocardial infarction. Thromb. Haemost. 63: 174-177.
54. Keber, I., J. Lavre, S. Suc, and D. Keber. 1994. The decrease of plasminogen activator inhibitor after normalization of triglycerides during treatment with fibrates. Fibrinolysis. 8: 57-59.
55. Broijersen, A., M. Eriksson, B. Wiman, B. Angelin, and P. Hjemdahl. 1996. Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels. Arterioscler. Thromb. Vasc. Biol. 16: 511-516.
56. Kockx, M., M. P. de Maat, H. C. Knipscheer, J. J. Kastelein, C. Kluft, H. M. Princen, and T. Kooistra. 1997. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients. Thromb. Haemost. 78: 1167-1172.
57. Dawson, S., and A. Henney. 1992. The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis. 95: 105-117.